Traditional Uses, Phytochemistry, Pharmacology and Toxicology of Rhizoma phragmitis: A Narrative Review
Abstract Rhizoma phragmitis is a common Chinese herbal medicine whose effects are defined as ‘clearing heat and fire, promoting fluid production to quench thirst, eliminating irritability, stopping vomiting, and disinhibiting urine’. During the Novel Coronavirus epidemic in 2020, the Weijing Decoction and Wuye Lugen Decoction, with Rhizoma phragmitis as the main herbal component, were included in The Pneumonia Treatment Protocol for Novel Coronavirus Infection (Trial Version 5) due to remarkable antiviral effects. Modern pharmacological studies have shown that Rhizoma phragmitis has antiviral, antioxidative, anti-inflammatory, analgesic, and hypoglycemic functions, lowers blood lipids and protects the liver and kidney. This review aims to provide a systematic summary of the botany, traditional applications, phytochemistry, pharmacology and toxicology of Rhizoma phragmitis..
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:28 |
|---|---|
| Enthalten in: |
Chinese journal of integrative medicine - 28(2022), 12 vom: 23. März, Seite 1127-1136 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Ren, Yuan [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| Themen: |
|---|
| Anmerkungen: |
© The Chinese Journal of Integrated Traditional and Western Medicine Press and Springer-Verlag GmbH Germany, part of Springer Nature 2022 |
|---|
| doi: |
10.1007/s11655-022-3572-1 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC2080040286 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | OLC2080040286 | ||
| 003 | DE-627 | ||
| 005 | 20230516185827.0 | ||
| 007 | tu | ||
| 008 | 230131s2022 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s11655-022-3572-1 |2 doi | |
| 035 | |a (DE-627)OLC2080040286 | ||
| 035 | |a (DE-He213)s11655-022-3572-1-p | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a ASIEN |q DE-1a |2 fid | ||
| 100 | 1 | |a Ren, Yuan |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Traditional Uses, Phytochemistry, Pharmacology and Toxicology of Rhizoma phragmitis: A Narrative Review |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a © The Chinese Journal of Integrated Traditional and Western Medicine Press and Springer-Verlag GmbH Germany, part of Springer Nature 2022 | ||
| 520 | |a Abstract Rhizoma phragmitis is a common Chinese herbal medicine whose effects are defined as ‘clearing heat and fire, promoting fluid production to quench thirst, eliminating irritability, stopping vomiting, and disinhibiting urine’. During the Novel Coronavirus epidemic in 2020, the Weijing Decoction and Wuye Lugen Decoction, with Rhizoma phragmitis as the main herbal component, were included in The Pneumonia Treatment Protocol for Novel Coronavirus Infection (Trial Version 5) due to remarkable antiviral effects. Modern pharmacological studies have shown that Rhizoma phragmitis has antiviral, antioxidative, anti-inflammatory, analgesic, and hypoglycemic functions, lowers blood lipids and protects the liver and kidney. This review aims to provide a systematic summary of the botany, traditional applications, phytochemistry, pharmacology and toxicology of Rhizoma phragmitis. | ||
| 650 | 4 | |a pharmacology | |
| 650 | 4 | |a phytochemistry | |
| 650 | 4 | |a Chinese medicine | |
| 700 | 1 | |a Cui, Ge-dan |4 aut | |
| 700 | 1 | |a He, Li-sha |4 aut | |
| 700 | 1 | |a Yao, Huan |4 aut | |
| 700 | 1 | |a Zi, Chang-yan |4 aut | |
| 700 | 1 | |a Gao, Yong-xiang |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Chinese journal of integrative medicine |d Springer Nature Singapore, 2003 |g 28(2022), 12 vom: 23. März, Seite 1127-1136 |w (DE-627)474568415 |w (DE-600)2171254-2 |w (DE-576)495279420 |x 1672-0415 |7 nnns |
| 773 | 1 | 8 | |g volume:28 |g year:2022 |g number:12 |g day:23 |g month:03 |g pages:1127-1136 |
| 856 | 4 | 1 | |u https://doi.org/10.1007/s11655-022-3572-1 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a FID-ASIEN | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 951 | |a AR | ||
| 952 | |d 28 |j 2022 |e 12 |b 23 |c 03 |h 1127-1136 | ||